Roche’s purpose, “Life is our purpose,” is at the heart of everything we do. Every day, our groundbreaking science, revolutionary medicines, and cutting-edge diagnostic solutions improve the lives of countless people worldwide. This has been our legacy for the past 125 years, and it will continue to guide us towards a promising future.
As we celebrate our 125-year anniversary, we have every reason to rejoice. Life is about celebrating, whether it’s creating new memories or cherishing the small moments of our past. This year, we not only celebrate our history and culture but also the enduring purpose that will lead Roche towards a sustainable and healthy future.
At Roche, we are driven by a purpose – doing now what patients need next. Regardless of our division, country, or business area, we all share the common goal of improving the lives of people in society, especially patients.
Roche was founded in 1896 by Fritz Hoffmann-La Roche in Basel, Switzerland, during the industrial revolution that was transforming Europe. He was one of the first to recognize the potential of industrial manufacturing in the fight against diseases. Since then, Roche has grown into one of the world‘s leading healthcare companies. Our focus is not only on inventing innovative drugs but also on ensuring access to them for patients. In fact, more than 30 of our medicines are included in the World Health Organization‘s list of essential medicines, including life-saving antibiotics, anti-malarial, and oncological drugs.
For the past 12 years, Roche has been recognized as one of the most sustainable companies in the pharmaceutical industry according to the Dow Jones Sustainability Index (DJSI). Our headquarters are in Basel, Switzerland, and we have a presence in over 100 countries. With a workforce of over 100,000 employees, we invested 12.2 billion Swiss Francs in research and development in 2020.
Roche’s subsidiary, Genentech, is based in the United States, and we are also a major shareholder in Chugai Pharmaceutical in Japan. Our medicines have made significant advancements in the fields of oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders. We are also a global leader in in vitro and molecular diagnostics for tumors and have a strong presence in diabetes management.
In recent years, Roche has made significant investments in genomic profiling and data collection, establishing ourselves as a leader in this area within the pharmaceutical industry. We are constantly innovating in the healthcare sector, and over the past 125 years, we have developed numerous groundbreaking medicines and diagnostic tests.
In conclusion, Roche’s purpose of improving lives has been the driving force behind our success for the past 125 years. We are committed to continuing this legacy and making a positive impact on society through our innovative medicines and diagnostic solutions.
Read More @ georgiatoday.ge